Correlation Between Universe Pharmaceuticals and Cardio Diagnostics

Can any of the company-specific risk be diversified away by investing in both Universe Pharmaceuticals and Cardio Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Universe Pharmaceuticals and Cardio Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Universe Pharmaceuticals and Cardio Diagnostics Holdings, you can compare the effects of market volatilities on Universe Pharmaceuticals and Cardio Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Universe Pharmaceuticals with a short position of Cardio Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Universe Pharmaceuticals and Cardio Diagnostics.

Diversification Opportunities for Universe Pharmaceuticals and Cardio Diagnostics

-0.71

Correlation Coefficient

Universe Pharmaceuticals  Cardio Diagnostics

Pay attention - limited upside

The 3 months correlation between Universe and Cardio is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Universe Pharmaceuticals and Cardio Diagnostics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardio Diagnostics and Universe Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Universe Pharmaceuticals are associated (or correlated) with Cardio Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardio Diagnostics has no effect on the direction of Universe Pharmaceuticals i.e., Universe Pharmaceuticals and Cardio Diagnostics go up and down completely randomly.

Pair Corralation between Universe Pharmaceuticals and Cardio Diagnostics

Considering the 90-day investment horizon Universe Pharmaceuticals is expected to under-perform the Cardio Diagnostics. But the stock apears to be less risky and, when comparing its historical volatility, Universe Pharmaceuticals is 2.07 times less risky than Cardio Diagnostics. The stock trades about -0.46 of its potential returns per unit of risk. The Cardio Diagnostics Holdings is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  78.00  in Cardio Diagnostics Holdings on October 9, 2024 and sell it today you would earn a total of  15.00  from holding Cardio Diagnostics Holdings or generate 19.23% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	95.0%
Values	Daily Returns

Universe Pharmaceuticals  vs.  Cardio Diagnostics Holdings

Universe Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Universe Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather unsteady basic indicators, Universe Pharmaceuticals exhibited solid returns over the last few months and may actually be approaching a breakup point.

Cardio Diagnostics

Risk-Adjusted Performance

17 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Cardio Diagnostics Holdings are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Cardio Diagnostics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Universe Pharmaceuticals and Cardio Diagnostics

The main advantage of trading using opposite Universe Pharmaceuticals and Cardio Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Universe Pharmaceuticals position performs unexpectedly, Cardio Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardio Diagnostics will offset losses from the drop in Cardio Diagnostics' long position.

The idea behind Universe Pharmaceuticals and Cardio Diagnostics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.